Profuse Technology

ProFuse is the skeletal muscle growth expert, developing innovative therapies for skeletal muscle loss and products for cultivated meat production. Addressing the critical unmet need for effective drugs for muscle-wasting diseases, ProFuse leverages its proprietary technological assets to efficiently and accurately discover novel muscle therapies. Our platform enables the high-throughput screening of thousands of compounds, identifying promising candidates with a high translational potential. For the cultivated meat industry, we sell cutting-edge products- cell lines and differentiation media supplements to significantly reduce costs, enhance muscle growth, increase yield and accelerate production cycles. ProFuse actively collaborates with leading companies seamlessly integrating our products and knowhow into their production processes. Founded in 2021, ProFuse licensed technology developed over four years of research at the Weizmann Institute of Science. Since then, we have achieved significant milestones, including winning first place in the 2021 Israel FoodTech Startup Competition and securing exclusive grants from both the European Innovation Council and the Israel Innovation Authority. We have launched two product lines and are actively supporting our cultivated meat customers in their scale-up efforts. We are particularly proud of our R&D team's focus on skeletal muscle biology which is strengthened by the expertise of Professors Eldad Tzahor (Weizmann Institute of Science, Israel) and Professor Shulamit Levenberg (Technion, Israel).